Aprea Therapeutics, Inc. (APRE) SEC Filings — 2025
12 SEC filings for Aprea Therapeutics, Inc. (APRE) in 2025.
Filings
- Aprea Therapeutics, Inc. 8-K Filing — 8-K · Dec 9, 2025
- Aprea Therapeutics Faces Going Concern Doubt Amid Cash Burn — 10-Q · Nov 12, 2025
- Aprea Therapeutics Files 8-K — 8-K · Oct 24, 2025
- Aprea Therapeutics Files 8-K — 8-K · Oct 15, 2025
- Aprea Therapeutics Files 8-K — 8-K · Sep 8, 2025
- Aprea's Cash Dwindles, Raising Going Concern Doubts Amid Rising R&D Costs — 10-Q · Aug 12, 2025
- Aprea Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 9, 2025
- Aprea Therapeutics Q1 2025 10-Q Filed — 10-Q · May 14, 2025
- Aprea Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 22, 2025
- Aprea Therapeutics Files 2024 10-K — 10-K · Mar 25, 2025
- Aprea Therapeutics Files 8-K — 8-K · Feb 5, 2025
- Aprea Therapeutics Files 8-K — 8-K · Jan 13, 2025